SEC Form 4 · accession 0001382963-16-000192
JUNIPER PHARMACEUTICALS INC · JNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bridget A Martell
Officer — Chief Medical Officer
Period of report
Feb 19, 2016
Accepted (ET)
Jul 6, 2016 · 4:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000821995
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $7.82 | Feb 19, 2016 | A | 50,000 | A | — | Feb 19, 2023 | Common stock, $0.01 par value per share | 50,000 | 50,000 | D |
Explanation of responses
- F1The option will be exercisable in 25% increments of the shares on each annual anniversary of the date of the grant.